ArticleSurgery today2026
Clinical outcomes of chimney endovascular aneurysm repair versus open surgical repair for short-neck abdominal aortic aneurysms.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chronic Thrombosed Abdominal Aortic Aneurysm Treated by Endovascular Aneurysm Repair Using Bifurcated Endograft: A Case Report.Surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the outcomes of chimney endovascular aneurysm repair (Ch-EVAR) and open surgical repair (OSR) for abdominal aortic aneurysm (AAA) in consideration of the lack of comparative evidence.
methodsThe subjects of this retrospective study were patients who underwent elective Ch-EVAR or OSR for short-neck AAAs between 2013 and 2020 at five vascular centers. The primary endpoint was 30-day mortality and the secondary endpoints were postoperative complications and midterm clinical outcomes, including renal function changes, reintervention, overall survival, and aneurysm-related mortality.
resultsWe analyzed 38 Ch-EVARs and 42 OSRs. The 30-day mortality rates were 2.6 and 2.4% in the Ch-EVAR and OSR groups, respectively (P = 1.00). The acute kidney injury incidence was higher in the OSR group than in the Ch-EVAR group (P < 0.01). The freedom from reintervention rate at 5 years was lower in the Ch-EVAR group than in the OSR group (81.0% vs. 100%, P = 0.04). Other midterm clinical outcomes did not differ between the groups.
conclusionsCh-EVAR may be a feasible treatment option for short-neck AAA; however, it should be limited to patients at high operative risk for OSR, considering the concern about its long-term durability.
Indexed as
Identifiers
40715820What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.